These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24989891)

  • 1. Deciding on success criteria for predictability of pharmacokinetic parameters from in vitro studies: an analysis based on in vivo observations.
    Abduljalil K; Cain T; Humphries H; Rostami-Hodjegan A
    Drug Metab Dispos; 2014 Sep; 42(9):1478-84. PubMed ID: 24989891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.
    Poulin P
    J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data.
    Poulin P; Haddad S
    J Pharm Sci; 2013 Sep; 102(9):3239-51. PubMed ID: 23494893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The volume of distribution is an indicator of poor in vitro-in vivo extrapolation of clearance for acidic drugs in the rat.
    Sohlenius-Sternbeck AK; Fagerholm U; Bylund J
    Xenobiotica; 2013 Aug; 43(8):671-8. PubMed ID: 23323549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
    Jones RD; Jones HM; Rowland M; Gibson CR; Yates JW; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4074-89. PubMed ID: 21452299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance.
    Scotcher D; Jones C; Rostami-Hodjegan A; Galetin A
    Eur J Pharm Sci; 2016 Oct; 94():59-71. PubMed ID: 27033147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods.
    Poulin P; Kenny JR; Hop CE; Haddad S
    J Pharm Sci; 2012 Feb; 101(2):838-51. PubMed ID: 22009717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of hybrid approach based on empirical and physiological concept for predicting pharmacokinetics in humans--usefulness of exponent on prospective evaluation of predictability.
    Sayama H; Komura H; Kogayu M
    Drug Metab Dispos; 2013 Feb; 41(2):498-507. PubMed ID: 23209193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies.
    Chen Y; Jin JY; Mukadam S; Malhi V; Kenny JR
    Biopharm Drug Dispos; 2012 Mar; 33(2):85-98. PubMed ID: 22228214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of metabolic drug clearance in humans: in vitro-in vivo extrapolation vs allometric scaling.
    Shiran MR; Proctor NJ; Howgate EM; Rowland-Yeo K; Tucker GT; Rostami-Hodjegan A
    Xenobiotica; 2006 Jul; 36(7):567-80. PubMed ID: 16864504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
    Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB
    Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
    Deguchi T; Watanabe N; Kurihara A; Igeta K; Ikenaga H; Fusegawa K; Suzuki N; Murata S; Hirouchi M; Furuta Y; Iwasaki M; Okazaki O; Izumi T
    Drug Metab Dispos; 2011 May; 39(5):820-9. PubMed ID: 21282406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation.
    Scotcher D; Jones C; Posada M; Galetin A; Rostami-Hodjegan A
    AAPS J; 2016 Sep; 18(5):1082-1094. PubMed ID: 27506526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations.
    Blanchard N; Hewitt NJ; Silber P; Jones H; Coassolo P; Lavé T
    J Pharm Pharmacol; 2006 May; 58(5):633-41. PubMed ID: 16640832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.
    De Buck SS; Mackie CE
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of human drug clearance by multiple metabolic pathways: integration of hepatic and intestinal microsomal and cytosolic data.
    Cubitt HE; Houston JB; Galetin A
    Drug Metab Dispos; 2011 May; 39(5):864-73. PubMed ID: 21303923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of drug concentration-time data in humans from animals: a comparison of three methods.
    Mahmood I; Goteti K
    Xenobiotica; 2012 Aug; 42(8):756-65. PubMed ID: 22360447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.